Evidence map›Paper›PMID 28198010›Full record

ArticleBritish journal of pharmacology2017

Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism.

Morena Zusso, Giulia Mercanti, Federica Belluti, Rita Maria Concetta Di Martino, Andrea Pagetta, Carla Marinelli, Paola Brun, Eugenio Ragazzi, Rita Lo, Stefano Stifani and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Pre- and Early Post-treatment WithFrontiers in pharmacology · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Effects of Curcumin on Microglial Cells.Neurotoxicity research · 2019
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Morena ZussoDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
Giulia MercantiDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
Federica BellutiDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
Rita Maria Concetta Di MartinoDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Bologna, Italy.
Andrea PagettaDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
Carla MarinelliDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
Paola BrunDepartment of Molecular Medicine, University of Padua, Padua, Italy.
Eugenio RagazziDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
Rita LoDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Stefano StifaniDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Pietro GiustiDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
Stefano MoroMolecular Modeling Section, Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
University of Padua · ITMontreal Neurological Institute and Hospital · CAUniversity of Bologna · IT

Funding

CIHR MOP-123270CIHR MOP-123500
6 · The paper itself

Abstract

background and purposeToll-like receptor 4 (TLR4) plays a key role in the induction of inflammatory responses both in peripheral organs and the CNS. Curcumin exerts anti-inflammatory functions by interfering with LPS-induced dimerization of TLR4-myeloid differentiation protein-2 (MD-2) complex and suppressing pro-inflammatory mediator release. However, the inhibitory mechanism of curcumin remains to be defined. EXPERIMENTAL APPROACH: Binding of bis-demethoxycurcumin (GG6) and its cyclized pyrazole analogue (GG9), lacking the 1,3-dicarbonyl function, to TLR4-MD-2 was determined using molecular docking simulations. The effects of these compounds on cytokine release and NF-κB activation were examined by ELISA and fluorescence staining in LPS-stimulated primary microglia. Interference with TLR4 dimerization was assessed by immunoprecipitation in Ba/F3 cells. KEY

resultsBoth curcumin analogues bound to the hydrophobic region of the MD-2 pocket. However, only curcumin and GG6, both possessing the 1,3-diketone moiety, inhibited LPS-induced TLR4 dimerization, activation of NF-κB and secretion of pro-inflammatory cytokines in primary microglia. Consistent with the ability of 1,3-diketones to coordinate divalent metal ions, LPS stimulation in a low magnesium environment decreased pro-inflammatory cytokine release and NF-κB p65 nuclear translocation in microglia and decreased TLR4-MD-2 dimerization in Ba/F3 cells. Curcumin and GG6 also significantly reduced cytokine output in contrast to the pyrazole analogue GG9. CONCLUSIONS AND IMPLICATIONS: These results indicate that phenolic 1,3-diketones, with a structural motif able to coordinate magnesium ions, can modulate LPS-mediated TLR4-MD-2 signalling. Taken together, these studies identify a previously uncharacterized mechanism involving magnesium, underlying the inflammatory responses to LPS.

Indexed as

AnimalsCells, CulturedCytokinesDose-Response Relationship, DrugFemaleInflammationKetonesLipopolysaccharidesLymphocyte Antigen 96MagnesiumMaleMicrogliaMolecular StructureRatsRats, Sprague-DawleySignal TransductionCytokinesKetonesLipopolysaccharidesLymphocyte Antigen 96MagnesiumTlr4 protein, ratToll-Like Receptor 4

Identifiers

PMID28198010
PMCPMC5406298
OpenAlexW2588926474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.